Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.63 USD | -0.59% | -21.32% | +356.01% |
05-08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
05-08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+356.01% | 2.54B | |
+24.46% | 44.96B | |
+0.35% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.52% | 26.08B | |
-21.15% | 19.03B | |
+6.53% | 12.75B | |
+28.83% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- William Blair Initiates Coverage for Janux Therapeutics With Outperform Rating